(a) Specifications.
The drug is in tablet form. Each tablet contains aminopropazine fumarate equivalent to 25 milligrams of aminopropazine base.
(b) Sponsor.
See No. 000061 in § 510.600(c) of this chapter.
(c) Conditions of use.
(1)
The drug is used in dogs and cats for reducing excessive smooth muscle contractions, such as occur in urethral spasms associated with urolithiasis. 1
(2)
It is administered at a dosage level of 1 to 2 milligrams per pound of body weight. The dosage can be repeated every 12 hours, as indicated. 1
(3)
Not for use in animals intended for food purposes.
(4)
For use only by or on the order of a licensed veterinarian. 1
Code of Federal Regulations
[40 FR 13838, Mar. 27, 1975, as amended at 46 FR 48642, Oct. 2, 1981; 61 FR 8873, Mar. 6, 1996; 62 FR 61624, Nov. 19, 1997]